Related references
Note: Only part of the references are listed.Nanocarriers targeting the diseases of the pancreas
Nurbanu Demirturk et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2022)
Targeted Polymeric Nanoparticles Based on Mangiferin for Enhanced Protection of Pancreatic β-Cells and Type 1 Diabetes Mellitus Efficacy
Mengdi Wang et al.
ACS APPLIED MATERIALS & INTERFACES (2022)
Exploring the Neuroprotective Potential of Rosiglitazone Embedded Nanocarrier System on Streptozotocin Induced Mice Model of Alzheimer's Disease
K. C. Sarathlal et al.
NEUROTOXICITY RESEARCH (2021)
Neuroprotective Efficacy of Co-Encapsulated Rosiglitazone and Vorinostat Nanoparticle on Streptozotocin Induced Mice Model of Alzheimer Disease
K. C. Sarathlal et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy
Jorge A. Roacho-Perez et al.
LIFE-BASEL (2021)
The direct effect of lobeglitazone, a new thiazolidinedione, on pancreatic beta cells: A comparison with other thiazolidinediones
Min Jeong Kwon et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
The effects of rosiglitazone on the neonatal rat cardiomyocyte transcriptome: a temporal analysis
Willian Abraham da Silveira et al.
PHARMACOGENOMICS (2019)
Protective effects of a G. lucidum proteoglycan on INS-1 cells against IAPP-induced apoptosis via attenuating endoplasmic reticulum stress and modulating CHOP/JNK pathways
Yan-Ming He et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice
Andras Franko et al.
SCIENTIFIC REPORTS (2018)
Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD
Huajie Li et al.
BIOSCIENCE REPORTS (2018)
High Concentrations of Rosiglitazone Reduce mRNA and Protein Levels of LRP1 in HepG2 Cells
Alejandro N. Rondon-Ortiz et al.
FRONTIERS IN PHARMACOLOGY (2017)
Inhibitory Mechanism of Epigallocatechin Gallate on Fibrillation and Aggregation of Amidated Human Islet Amyloid Polypeptide
Zhi-Xue Xu et al.
CHEMPHYSCHEM (2017)
Tat-biliverdin reductase A protects INS-1 cells from human islet amyloid polypeptide-induced cytotoxicity by alleviating oxidative stress and ER stress
Su Jin Lee et al.
CELL BIOLOGY INTERNATIONAL (2017)
Peroxisome Proliferator-activated Receptor- Activation Augments the -Cell Unfolded Protein Response and Rescues Early Glycemic Deterioration and Cell Death in Non-obese Diabetic Mice
Aarthi V. Maganti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) Aggregates
Clara Westwell-Roper et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
CHOP Contributes to, But Is Not the Only Mediator of, IAPP Induced β-Cell Apoptosis
T. Gurlo et al.
MOLECULAR ENDOCRINOLOGY (2016)
Acute Exercise Improves Insulin Clearance and Increases the Expression of Insulin-Degrading Enzyme in the Liver and Skeletal Muscle of Swiss Mice
Mirian A. Kurauti et al.
PLOS ONE (2016)
Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study
Glauce Cordeiro Ulhoa Tostes et al.
DIABETOLOGY & METABOLIC SYNDROME (2016)
Fibril Breaking Accelerates α-Synuclein Fibrillization
Volodymyr V. Shvadchak et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2015)
Selenium-enriched Spirulina protects INS-1E pancreatic beta cells from human islet amyloid polypeptide-induced apoptosis through suppression of ROS-mediated mitochondrial dysfunction and PI3/AKT pathway
Xiao-Ling Li et al.
EUROPEAN JOURNAL OF NUTRITION (2015)
GLP-1R-Targeting Magnetic Nanoparticles for Pancreatic Islet Imaging
Ping Wang et al.
DIABETES (2014)
Regulation of Insulin Degrading Enzyme Activity by Obesity-Associated Factors and Pioglitazone in Liver of Diet-Induced Obese Mice
Xiuqing Wei et al.
PLOS ONE (2014)
Ginsenoside Rg1 Decreases Aβ1-42 Level by Upregulating PPARγ and IDE Expression in the Hippocampus of a Rat Model of Alzheimer's Disease
QianKun Quan et al.
PLOS ONE (2013)
Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5′-AMP-activated protein kinase modulation
Jie Wu et al.
ENDOCRINE (2013)
Silibinin inhibits the toxic aggregation of human islet amyloid polypeptide
Biao Cheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Human-IAPP disrupts the autophagy/lysosomal pathway in pancreatic β-cells: protective role of p62-positive cytoplasmic inclusions
J. F. Rivera et al.
CELL DEATH AND DIFFERENTIATION (2011)
Involvement of mitochondrial dysfunction in human islet amyloid polypeptide-induced apoptosis in INS-1E pancreatic beta cells: An effect attenuated by phycocyanin
Xiao-Ling Li et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Peter Walter et al.
SCIENCE (2011)
Molecular mechanism by which pioglitazone preserves pancreatic β-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARγ agonist
Yukiko Kanda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Rosiglitazone protects the pancreatic β-cell death induced by cyclosporine A
Ji-Won Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Antagonist of peroxisome proliferator-activated receptor γ induces cerebellar amyloid-β levels and motor dysfunction in APP/PS1 transgenic mice
Jing Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
PPARγ transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons
Jing Du et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Inhibiting Islet Amyloid Polypeptide Fibril Formation by the Red Wine Compound Resveratrol
Rajesh Mishra et al.
CHEMBIOCHEM (2009)
Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice
M. Akiyama et al.
DIABETOLOGIA (2009)
Peroxisome Proliferator-Activated Receptor γ Activation Restores Islet Function in Diabetic Mice through Reduction of Endoplasmic Reticulum Stress and Maintenance of Euchromatin Structure
Carmella Evans-Molina et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Philip D. Home et al.
LANCET (2009)
Induction of endoplasmic reticulum stress-induced β-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide
Chang-jiang Huang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic β-cell apoptosis
Silvia Casas et al.
DIABETES (2007)
High expression rates of human islet amyloid polypeptide induce endoplasmic reticulum stress-mediated β-cell apoptosis, a characteristic of humans with type 2 but not type 1 diabetes
Chang-jiang Huang et al.
DIABETES (2007)
Fiber-dependent amyloid formation as catalysis of an existing reaction pathway
Amy M. Ruschak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Endoplasmic reticulum stress: Signaling the unfolded protein response
Elida Lai et al.
PHYSIOLOGY (2007)
Amylinergic control of food intake
Thomas A. Lutz
PHYSIOLOGY & BEHAVIOR (2006)
Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1α gene transcription:: An autoregulatory loop controls PGC-1α expression in adipocytes via peroxisome proliferator-activated receptor-γ coactivation
Elayne Hondares et al.
ENDOCRINOLOGY (2006)
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
Ward A. Pedersen et al.
EXPERIMENTAL NEUROLOGY (2006)
Islet amyloid polypeptide inserts into phospholipid monolayers as monomer
MFM Engel et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
Intracellular amyloid-like deposits contain unprocessed pro-islet amyloid polypeptide (proIAPP) in beta cells of transgenic mice overexpressing the gene for human IAPP and transplanted human islets
JF Paulsson et al.
DIABETOLOGIA (2006)
Proteolysis: from the lysosome to ubiquitin and the proteasome
A Ciechanover
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures
RG Bennett et al.
DIABETES (2003)
Replication increases β-cell vulnerability to human islet amyloid polypeptide-induced apoptosis
RA Ritzel et al.
DIABETES (2003)
Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets
B Åkesson et al.
REGULATORY PEPTIDES (2003)
beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
AE Butler et al.
DIABETES (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
PPARγ:: a nuclear regulator of metabolism, differentiation, and cell growth
ED Rosen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
β-cell mass dynamics in Zucker diabetic fatty rats -: Rosiglitazone prevents the rise in net cell death
DT Finegood et al.
DIABETES (2001)
High glucose concentration favors the selective secretion of islet amyloid polypeptide through a constitutive secretory pathway in human pancreatic islets
R Gasa et al.
PANCREAS (2001)
Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats
RD Reidelberger et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2001)
Degradation of amylin by insulin-degrading enzyme
RG Bennett et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)